title: Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
authors: A Y
authors: AY
authors: Coban
authors: E
authors: E
authors: Tanyel
authors: N
authors: N
authors: Tasdelen Fisgin
authors: O
authors: O
authors: Darka
authors: N
authors: N
authors: Tulek
authors: B
authors: B
authors: Durupinar
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017347:Brucella melitensis / Q000187:drug effects*; D002006:Brucellosis / Q000188:drug therapy; D002939:Ciprofloxacin / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation; D012293:Rifampin / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D013752:Tetracycline; D012293:Rifampin